Updated procurement data for antiretroviral (ARV) medicines in Kazakhstan and Kyrgyzstan for 2021–2024 are now available.

Users can:

• track annual price dynamics for individual ARV medicines;
• compare procurement costs across countries in the region;
• analyze treatment coverage trends;
• review actual government spending on ARV procurement.

The publication of country-level data strengthens transparency and supports evidence-based analysis of factors influencing access to treatment. This information helps stakeholders refine budgeting approaches, evaluate procurement decisions, and identify opportunities for more efficient negotiations.

In 2026, additional expansion is planned: new countries and complementary datasets will be added, enabling a more comprehensive view of pricing and treatment access across the region.

The data on Kazakhstan and Kyrgyzstan were prepared by the International Treatment Preparedness Coalition in Eastern Europe and Central Asia (ITPC EECA), in collaboration with country partners — the Partnership Network Association and the Answer-Kazakhstan Association — within the Make Medicines Affordable consortium.